OPTION CARE HEALTH INC (OPCH)
US68404L2016 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to OPCH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 31.49. This target is 38.06% above the current price.
OPCH was analyzed by 15 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about OPCH.
In the previous month the buy percentage consensus was at a similar level.
OPCH was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-05 | UBS | Initiate | Neutral |
| 2024-11-05 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2024-11-01 | Truist Securities | Maintains | Buy -> Buy |
| 2024-10-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-31 | Jefferies | Downgrade | Buy -> Hold |
| 2024-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-30 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-25 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-16 | JMP Securities | Initiate | Market Outperform |
| 2024-04-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-03-04 | Jefferies | Maintains | Buy -> Buy |
| 2024-02-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-10-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-10-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-07-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-06-27 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-05-05 | Barrington Research | Maintains | Outperform |
| 2023-05-05 | Deutsche Bank | Maintains | Buy |
| 2023-02-27 | Jefferies | Reiterate | Buy |
| 2022-10-28 | Barrington Research | Maintains | Outperform |
| 2022-08-22 | Goldman Sachs | Maintains | Buy |
| 2022-07-28 | Barrington Research | Maintains | Outperform |
| 2021-08-04 | Canaccord Genuity | Maintains | Buy |
| 2021-07-19 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2021-03-12 | Canaccord Genuity | Maintains | Buy |